Skip Content
Page Banner Image

2020 Postcard from Palm Springs

Highlights from the 2020 CHDI HD Therapeutics Conference are now here!


This year’s Postcard covers HTT-lowering therapeutics, including an update on the Roche ASO Phase 3 trial, brand new therapeutic approaches that have come out of the GWAS modifier gene studies, and a just-published study of premanifest HD in young adults.

We support those facing huntington disease
 Latest Blog


Have questions? Send us an email at:



Stay in Touch!
Enter your email address below to receive occasional updates.

Newsletter Sign-up

Copyright © Huntington Society of Canada. All Rights Reserved. Charitable Registration Number 11896 5516 RR0001